Seelos Therapeutics Inc (SEEL)
1.88
-0.46
(-19.66%)
USD |
NASDAQ |
May 17, 16:00
1.88
0.00 (0.00%)
After-Hours: 20:00
Seelos Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| September 30, 2018 | |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.209M |
| September 30, 2017 | 0.25M |
| June 30, 2017 | 0.25M |
| March 31, 2017 | 11.50M |
| December 31, 2016 | 0.003M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.168M |
| March 31, 2016 | 0.094M |
| December 31, 2015 | -0.116M |
| September 30, 2015 | -0.028M |
| June 30, 2015 | -0.013M |
| March 31, 2015 | -0.165M |
| December 31, 2014 | -0.08M |
| September 30, 2014 | -0.068M |
| June 30, 2014 | 0.598M |
| March 31, 2014 | -0.305M |
| December 31, 2013 | -0.229M |
| September 30, 2013 | 0.072M |
| June 30, 2013 | 0.037M |
| March 31, 2013 | 4.829M |
| December 31, 2012 | -0.342M |
| Date | Value |
|---|---|
| September 30, 2012 | 1.688M |
| June 30, 2012 | 0.002M |
| March 31, 2012 | -0.28M |
| December 31, 2011 | 0.5425M |
| September 30, 2011 | -0.0218M |
| June 30, 2011 | -0.1688M |
| March 31, 2011 | -0.0079M |
| December 31, 2010 | -0.0931M |
| September 30, 2010 | 0.5558M |
| June 30, 2010 | -0.8173M |
| March 31, 2010 | -0.0814M |
| December 31, 2009 | -0.0026M |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.1721M |
| March 31, 2009 | 0.175M |
| December 31, 2008 | 0.075M |
| September 30, 2008 | -0.0112M |
| June 30, 2008 | -0.0037M |
| March 31, 2008 | 0.736M |
| December 31, 2007 | 0.2366M |
| September 30, 2007 | 1.462M |
| June 30, 2007 | -0.0492M |
| March 31, 2007 | -1.50M |
| December 31, 2006 | 0.9935M |
| September 30, 2006 | 0.0892M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| 180 Life Sciences Corp | -- |
| Acurx Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.911M |
| Cash from Financing (Quarterly) | 2.323M |
| Free Cash Flow | -23.91M |
| Free Cash Flow Per Share (Quarterly) | -2.205 |
| Free Cash Flow Yield | -2.03K% |